![Dror Mevorach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dror Mevorach
Corporate Officer/Principal bei
Hadassah University Hospital
Profil
Dror Mevorach was the founder of Enlivex Therapeutics Ltd. (2005) as Chief Scientific & Medical Officer.
Dr. Mevorach was the founder of Enlivex Therapeutics Ltd. (2009) as Chief Scientific & Medical Officer.
Dr. Mevorach is currently the Chairman-Medicine at Hadassah University Hospital.
Dr. Mevorach holds a doctorate from Technion-Israel Institute of Technology.
Aktive Positionen von Dror Mevorach
| Unternehmen | Position | Beginn |
|---|---|---|
Hadassah University Hospital
 Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Dror Mevorach
| Unternehmen | Position | Ende |
|---|---|---|
| ENLIVEX LTD. | Gründer | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Gründer | - |
Ausbildung von Dror Mevorach
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Health Services |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
